{
    "clinical_study": {
        "@rank": "129482", 
        "arm_group": [
            {
                "arm_group_label": "Group 1: Adults", 
                "arm_group_type": "Experimental", 
                "description": "Participants 18 through 64 years of age will receive a single booster dose of Tdap vaccine (ADACEL)."
            }, 
            {
                "arm_group_label": "Group 2: Children", 
                "arm_group_type": "Experimental", 
                "description": "Participants 4 through 8 years of age will receive a single booster dose of Tdap vaccine (ADACEL)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to assess the safety profile of ADACEL vaccine in a small number of\n      participants in China.\n\n      Primary objective:\n\n        -  To describe the safety in terms of occurrence of serious adverse reactions and grade 3\n           adverse reactions after administration of Sanofi Pasteur's Tdap vaccine (ADACEL) given\n           as a single dose in 20 adults and 20 children.\n\n      Secondary objective:\n\n        -  To describe the full reactogenicity profile after administration of sanofi pasteur's\n           Tdap vaccine (ADACEL) given as a single dose in 20 adults and 20 children."
        }, 
        "brief_title": "Study of the Tdap Combined Vaccine (ADACEL\u2122) as a Booster Dose in Healthy Adults and Children in China", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Adults 18 to 64 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                            "title": "ADACEL\u2122 Vaccine Group 1"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Children 4 to 8 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                            "title": "ADACEL\u2122 Vaccine Group 2"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "40"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "20"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "20"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "20"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "20"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "14.4", 
                                                "@value": "44.2"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "1.1", 
                                                "@value": "5.8"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "21.9", 
                                                "@value": "25.0"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "Years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "14"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "24"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "16"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "40"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "China"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "Participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications"
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Solicited injection site reactions: Pain, Erythema, and Swelling; Solicited systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nChina Food and Drug Administration (CFDA)-defined Grade 3 solicited reactions: Pain, incapacitating, unable to perform usual activities (Children, Group 1) and significant, prevents daily activity  (Adults, Group 1); All Participants, Erythema and Swelling >30 mm; Fever (temperature) >39\u02daC; Headache, Malaise, and Myalgia, significant, prevents daily activity.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Adults 18 through 64 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                                    "title": "ADACEL\u2122 Vaccine Group 1"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Children 4 through 8 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                                    "title": "ADACEL\u2122 Vaccine Group 2"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "20"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "20"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Pain"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Erythema"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Swelling"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Fever"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Headache"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Malaise"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Myalgia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Serious adverse events"
                                            }
                                        ]
                                    }, 
                                    "description": "Solicited injection site reactions: Pain, Erythema, and Swelling; Solicited systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nChina Food and Drug Administration (CFDA)-defined Grade 3 solicited reactions: Pain, incapacitating, unable to perform usual activities (Children, Group 1) and significant, prevents daily activity  (Adults, Group 1); All Participants, Erythema and Swelling >30 mm; Fever (temperature) >39\u02daC; Headache, Malaise, and Myalgia, significant, prevents daily activity.", 
                                    "param": "Number", 
                                    "title": "Number of Participants Reporting Serious Adverse Events and Grade 3 Adverse Reactions Following a Single Booster Dose of Adacel\u2122 Vaccine", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Serious adverse events and solicited injection site reactions and systemic reactions were assessed in the Safety Analysis Set.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 0 up to Day 28 post-vaccination", 
                        "title": "Number of Participants Reporting Serious Adverse Events and Grade 3 Adverse Reactions Following a Single Booster Dose of Adacel\u2122 Vaccine", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Solicited injection site reactions: Pain, Erythema, and Swelling; Solicited systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nChina Food and Drug Administration (CFDA)-defined Grade 3 solicited reactions: Pain, incapacitating, unable to perform usual activities (Children, Group 1) and significant, prevents daily activity  (Adults, Group 1); All Participants, Erythema and Swelling >30 mm; Fever (temperature) >39\u02daC; Headache, Malaise, and Myalgia, significant, prevents daily activity.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Adults 18 through 64 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                                    "title": "ADACEL\u2122 Vaccine Group 1"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Children 4 through 8 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                                    "title": "ADACEL\u2122 Vaccine Group 2"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "20"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "20"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "9"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Injection site Pain"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Pain"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "9"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Injection site Erythema"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Erythema"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "9"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Injection site Swelling"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Swelling"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fever"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Fever"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Headache"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Headache"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Malaise"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Malaise"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Myalgia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Myalgia"
                                            }
                                        ]
                                    }, 
                                    "description": "Solicited injection site reactions: Pain, Erythema, and Swelling; Solicited systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nChina Food and Drug Administration (CFDA)-defined Grade 3 solicited reactions: Pain, incapacitating, unable to perform usual activities (Children, Group 1) and significant, prevents daily activity  (Adults, Group 1); All Participants, Erythema and Swelling >30 mm; Fever (temperature) >39\u02daC; Headache, Malaise, and Myalgia, significant, prevents daily activity.", 
                                    "param": "Number", 
                                    "title": "Number of Participants Reporting a Solicited Injection Site or Systemic Reaction Following a Single Booster Dose of Adacel\u2122 Vaccine", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Solicited injection site reactions and systemic reactions were assessed in the Safety Analysis Set.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 0 up to Day 7 post-vaccination", 
                        "title": "Number of Participants Reporting a Solicited Injection Site or Systemic Reaction Following a Single Booster Dose of Adacel\u2122 Vaccine", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Adults 18 through 64 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                            "title": "ADACEL\u2122 Vaccine Group 1 (Adults)"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Children 4 through 8 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                            "title": "ADACEL\u2122 Vaccine Group 2 (Children)"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "20", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "20", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "20", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "20", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "A total of 40 participants who met all of the inclusion and none of the exclusion criteria were enrolled and vaccinated in this study.", 
                "recruitment_details": "The study participants were enrolled from 27 August 2013 through 08 October 2013 at 1 clinic center in China."
            }, 
            "point_of_contact": {
                "email": "RegistryContactUs@sanofipasteur.com", 
                "name_or_title": "Medical Director", 
                "organization": "Sanofi Pasteur Inc."
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Adults 18 through 64 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                            "title": "ADACEL\u2122 Vaccine Group 1"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Children 4 through 8 years of age received a single booster dose of Tdap vaccine (ADACEL\u2122)", 
                            "title": "ADACEL\u2122 Vaccine Group 2"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "6", 
                                                "@subjects_at_risk": "20"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "9", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "6", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@events": "9", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "20"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Injection site Pain", 
                                                "@vocab": "MedDRA version 16.0"
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@events": "9", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "20"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Injection site Erythema", 
                                                "@vocab": "MedDRA version 16.0"
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "3", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@events": "9", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "20"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Injection site Swelling", 
                                                "@vocab": "MedDRA version 16.0"
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@events": "3", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "20"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Fever", 
                                                "@vocab": "MedDRA version 16.0"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "20"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Upper respiratory tract infection", 
                                            "@vocab": "MedDRA version 16.0"
                                        }
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Systematic Assessment", 
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Myalgia", 
                                            "@vocab": "MedDRA version 16.0"
                                        }
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Systematic Assessment", 
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Headache", 
                                            "@vocab": "MedDRA version 16.0"
                                        }
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "MedDRA 16.0", 
                    "frequency_threshold": "5.00"
                }, 
                "time_frame": "Adverse event data were collected from Day 0 (post-vaccination) up to Day 28 post-vaccination."
            }
        }, 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Diphtheria", 
            "Tetanus", 
            "Pertussis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diphtheria", 
                "Whooping Cough", 
                "Tetanus", 
                "Tetany"
            ]
        }, 
        "detailed_description": {
            "textblock": "Participants will be enrolled sequentially into the study groups to receive one dose of\n      ADACEL at Day 0 (Visit 1) and will be followed-up for 28-35 days."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Group 1: Aged 18 through 64 years on the day of inclusion Group 2: Aged 4 through 8\n             years on the day of inclusion\n\n          -  Informed consent form signed by the subject (Group 1) or by the parent(s) or legal\n             representative (Group 2)\n\n          -  Subject (Group 1 and 2) and parent/legal representative (Group 2 only) able to attend\n             all scheduled visits and to comply with all trial procedures\n\n          -  Group 1 only: For a woman of child-bearing potential, avoid becoming pregnant (use of\n             an effective method of contraception or abstinence) from at least 4 weeks prior to\n             vaccination, until at least 4 weeks after vaccination\n\n          -  Group 2 only: Written documentation of complete primary series and fourth dose of\n             Diphtheria, Tetanus, Pertussis (DTP) vaccine as per China National Immunization\n             Recommendations\n\n        Exclusion Criteria:\n\n          -  Group 1 only: For a woman of child-bearing potential, known pregnancy or positive\n             serum or urine pregnancy test\n\n          -  Group 1 only: Currently breast-feeding a child\n\n          -  Participation in another clinical trial investigating a vaccine, drug, medical\n             device, or a medical procedure in the 4 weeks preceding the trial vaccination\n\n          -  Planned participation in another clinical trial during the present trial period\n\n          -  Known or suspected congenital or acquired immunodeficiency; or receipt of\n             immunosuppressive therapy such as anti-cancer chemotherapy or radiation therapy\n             within the preceding 6 months; or long-term systemic corticosteroids therapy\n             (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months)\n\n          -  Known systemic hypersensitivity to any of the vaccine components, or history of a\n             life-threatening reaction to the vaccine or to a vaccine containing any of the same\n             substances\n\n          -  Chronic illness that, in the opinion of the Investigator, is at a stage that could\n             interfere with trial conduct or completion\n\n          -  Group 1 only: Current alcohol abuse or drug addiction that may interfere with the\n             ability to comply with trial procedures\n\n          -  Receipt or planned receipt of any vaccine in the 4 weeks preceding or following trial\n             vaccination, except for influenza vaccination, which may be received at least two\n             weeks before the study vaccine\n\n          -  Self-reported seropositivity for Human Immunodeficiency Virus (HIV), Hepatitis B or\n             Hepatitis C\n\n          -  History of diphtheria, tetanus, or pertussis infection (confirmed either clinically,\n             serologically or microbiologically)\n\n          -  Previous fifth vaccination against pertussis disease and/or previous sixth\n             vaccination against diphtheria and tetanus disease with either the trial vaccine or\n             another vaccine (except Tetanus-prone wound management in Group 1)\n\n          -  Subject at high risk for diphtheria, tetanus, or pertussis infection during the\n             trial, including persons who have exposure (e.g., member of a household with another\n             infected member, travelers to or residents of areas where one of this disease is\n             hyperendemic or epidemic, or microbiologists routinely working with one of these\n             pathogens,)\n\n          -  Self-reported thrombocytopenia, bleeding disorder or receipt of anticoagulants in the\n             3 weeks preceding inclusion, contraindicating IM vaccination\n\n          -  Group 1 only: Subjects deprived of freedom by an administrative or court order, or in\n             an emergency setting, or hospitalized involuntarily\n\n          -  History of contra-indication to vaccination with pertussis containing vaccine,\n             including:\n\n          -  Encephalopathy (eg, coma, decreased level of consciousness, prolonged seizures)\n             within 7 days of a previous dose of a pertussis containing vaccine that is not\n             attributable to another identifiable cause\n\n          -  Identified as employees of the Investigator or study center, with direct involvement\n             in the proposed study or other studies under the direction of that Investigator or\n             study center, as well as immediate family members (i.e. husband, wife and their\n             children, adopted or natural) of the employees or the Investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "64 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 28, 2013", 
        "firstreceived_results_date": "March 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01933776", 
            "org_study_id": "Td527", 
            "secondary_id": "U1111-1127-7738"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group 1: Adults", 
                "description": "0.5 mL, Intramuscular (IM)", 
                "intervention_name": "Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap", 
                "intervention_type": "Biological", 
                "other_name": "ADACEL\u2122"
            }, 
            {
                "arm_group_label": "Group 2: Children", 
                "description": "0.5 mL, Intramuscular (IM)", 
                "intervention_name": "Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap", 
                "intervention_type": "Biological", 
                "other_name": "ADACEL\u2122"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Diphtheria", 
            "Tetanus", 
            "Pertussis", 
            "ADACEL\u00ae", 
            "Tdap vaccine"
        ], 
        "lastchanged_date": "March 17, 2014", 
        "link": [
            {
                "url": "http://www.sanofipasteur.com"
            }, 
            {
                "url": "http://www.sanofi.com"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Jiangsu", 
                    "country": "China", 
                    "state": "Jiangsu"
                }
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Safety Study of the Tdap Combined Vaccine (ADACEL\u2122) as a Booster Dose in Healthy Adults and Children in China", 
        "overall_official": {
            "affiliation": "Sanofi Pasteur Inc.", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Solicited injection site reactions: Pain, Erythema, and Swelling; Solicited systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nChina Food and Drug Administration (CFDA)-defined Grade 3 solicited reactions: Pain, incapacitating, unable to perform usual activities (Children, Group 1) and significant, prevents daily activity  (Adults, Group 1); All Participants, Erythema and Swelling >30 mm; Fever (temperature) >39\u02daC; Headache, Malaise, and Myalgia, significant, prevents daily activity.", 
            "measure": "Number of Participants Reporting Serious Adverse Events and Grade 3 Adverse Reactions Following a Single Booster Dose of Adacel\u2122 Vaccine", 
            "safety_issue": "No", 
            "time_frame": "Day 0 up to Day 28 post-vaccination"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01933776"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Solicited injection site reactions: Pain, Erythema, and Swelling; Solicited systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nChina Food and Drug Administration (CFDA)-defined Grade 3 solicited reactions: Pain, incapacitating, unable to perform usual activities (Children, Group 1) and significant, prevents daily activity  (Adults, Group 1); All Participants, Erythema and Swelling >30 mm; Fever (temperature) >39\u02daC; Headache, Malaise, and Myalgia, significant, prevents daily activity.", 
            "measure": "Number of Participants Reporting a Solicited Injection Site or Systemic Reaction Following a Single Booster Dose of Adacel\u2122 Vaccine", 
            "safety_issue": "No", 
            "time_frame": "Day 0 up to Day 7 post-vaccination"
        }, 
        "source": "Sanofi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanofi Pasteur, a Sanofi Company", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}